Article
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Mar 2021
Mehrvarz Sarshekeh Amir, Alshenaifi Jumanah, Roszik Jason, Manyam Ganiraju C, Advani Shailesh M, Katkhuda Riham, Verma Anuj, Lam Michael, Willis Jason, Shen John Paul, Morris Jeffrey, Davis Jennifer S, Loree Jonathan M, Lee Hey Min, Ajani Jaffer A, Maru Dipen M, Overman Michael J, Kopetz Scott
Abstract excerpt
PURPOSE: AT-rich interactive domain 1A (ARID1A) is commonly mutated in colorectal cancer, frequently resulting in truncation and loss of protein expression. ARID1A recruits MSH2 for mismatch repair during DNA replication. ARID1A deficiency promotes hypermutability and immune activation in preclinical models, but its role in patients with colorectal cancer is being explored. EXPERIMENTAL DESIGN: The DNA sequencing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
